A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days

Daniel G. Wootton, Laura Dickinson, Henry Pertinez, Joanne Court, Odiri Eneje, Lynne Keogan, Laura Macfarlane, Sarah Wilks, Jane Gallagher, Mark Woodhead, Stephen B. Gordon, Peter J. Diggle

Source: Eur Respir J, 49 (6) 1602170; 10.1183/13993003.02170-2016
Journal Issue: June

Congress or journal article abstractFull text journal articlePDF journal article, handout or slidesCME test or case report

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Daniel G. Wootton, Laura Dickinson, Henry Pertinez, Joanne Court, Odiri Eneje, Lynne Keogan, Laura Macfarlane, Sarah Wilks, Jane Gallagher, Mark Woodhead, Stephen B. Gordon, Peter J. Diggle. A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days. Eur Respir J, 49 (6) 1602170; 10.1183/13993003.02170-2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An RDW-based score predicts mid-term mortality in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation study
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019


To establish the characteristics which influence patients with an acute exacerbation of COPD to die within 2 weeks of hospital admission compared to those after a 2-week period
Source: Eur Respir J 2005; 26: Suppl. 49, 283s
Year: 2005

An RDW-based clinical model predicts long-term survival in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation multicentric study
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


A clinical and outcomes assessment of the management of acute episodes of chronic bronchitis (AECB) : the MOSAIC study - baseline characteristics of screened patients
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002

Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


A delay in reaching time to clinical stability (tcs) for hospitalized patients with community-acquired pneumonia (CAP) is associated with failure within 30 days after hospital discharge
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011

Cardiopulmonary exercise testing to assess persistent symptoms at 6 months in people with COVID-19 who survived hospitalisation – A pilot study.
Source: Virtual Congress 2021 – Assessing the impact of COVID-19 on lung function
Year: 2021


Different factors have impact on severe pneumonia resolution and mortality after the initial treatment period
Source: Eur Respir J 2003; 22: Suppl. 45, 150s
Year: 2003

Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged >=75 yrs
Source: Eur Respir J 2001; 17: 200-205
Year: 2001



Incidence of COPD in a sample of patients with psychosis: preliminary data from a 10 years longitudinal study
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia
Source: Eur Respir J 2001; 18: 362-368
Year: 2001



Are patients who report persistent symptoms and days lost due to asthma more likely to be hospitalised in the subsequent year?
Source: Eur Respir J 2002; 20: Suppl. 38, 204s
Year: 2002

Effect on outcome of antibiotic treatment during the 2 weeks before hospital admission for community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010


The general evaluation of community acquired pneumonia patients treated in our clinic
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004

The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma
Source: International Congress 2017 – Bronchial asthma management
Year: 2017


Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007


Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

A new treatment algorithm for acute exacerbation of IPF: a retrospective cohort study.
Source: International Congress 2019 – Recent developments in intensive care unit medicine
Year: 2019


An analysis of clinical features of hospitalized asthmatic children over a 5-year period: a single center experience
Source: International Congress 2017 – Diagnostic tools in paediatric asthma
Year: 2017